Texas OK’s $50 Million for Ibogaine Research

Texas OK’s $50 Million for Ibogaine Research

The New York Times - Business:

The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in treating addiction and post-traumatic stress disorder.

Andrew Jacobs
Author: Andrew Jacobs

This post first appeared in The New York Times - Business. Read the original article.

Leave a Comment

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *